Perrigo Price to Free Cash Flow Ratio 2010-2023 | PRGO
Perrigo Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2024-03-28 | 32.19 | 14.34 | |
2023-12-31 | 31.88 | $2.25 | 14.20 |
2023-09-30 | 31.37 | $2.08 | 15.11 |
2023-06-30 | 33.08 | $1.51 | 21.91 |
2023-03-31 | 34.66 | $0.94 | 36.73 |
2022-12-31 | 32.69 | $1.57 | 20.85 |
2022-09-30 | 33.92 | $-0.72 | 0.00 |
2022-06-30 | 38.32 | $1.44 | 26.57 |
2022-03-31 | 36.06 | $-2.75 | 0.00 |
2021-12-31 | 36.24 | $-3.03 | 0.00 |
2021-09-30 | 43.80 | $-1.80 | 0.00 |
2021-06-30 | 42.19 | $-2.13 | 0.00 |
2020-12-31 | 40.70 | $3.40 | 11.99 |
2020-09-30 | 41.59 | $5.23 | 7.95 |
2020-06-30 | 49.86 | $4.76 | 10.47 |
2020-03-31 | 43.20 | $3.60 | 12.01 |
2019-12-31 | 46.21 | $2.81 | 16.42 |
2021-03-31 | 37.05 | $1.18 | 31.27 |
2019-09-30 | 49.79 | $2.58 | 19.31 |
2019-06-30 | 42.23 | $2.71 | 15.59 |
2019-03-31 | 42.50 | $2.96 | 14.36 |
2018-12-31 | 34.07 | $3.55 | 9.61 |
2018-09-30 | 62.24 | $3.76 | 16.57 |
2018-06-30 | 63.94 | $4.14 | 15.43 |
2018-03-31 | 72.90 | $4.20 | 17.34 |
2017-12-31 | 76.05 | $4.28 | 17.77 |
2017-09-30 | 73.73 | $4.30 | 17.15 |
2017-06-30 | 65.64 | $4.36 | 15.07 |
2017-03-31 | 57.58 | $4.58 | 12.56 |
2016-12-31 | 72.03 | $3.83 | 18.81 |
2016-09-30 | 79.77 | $0.05 | 1621.39 |
2016-06-30 | 78.21 | $0.99 | 78.63 |
2016-03-31 | 110.18 | $1.29 | 85.54 |
2015-12-31 | 124.48 | $2.69 | 46.19 |
2015-09-30 | 135.18 | $6.40 | 21.12 |
2015-03-31 | 142.11 | $2.03 | 69.99 |
2014-12-31 | 143.38 | $3.07 | 46.73 |
2014-09-30 | 128.74 | $2.00 | 64.52 |
2014-06-30 | 124.85 | $1.44 | 86.47 |
2014-03-31 | 132.37 | $0.18 | 718.25 |
2013-12-31 | 131.26 | $1.44 | 90.91 |
2013-09-30 | 105.47 | $2.36 | 44.71 |
2013-06-30 | 103.36 | $2.01 | 51.33 |
2013-03-31 | 101.35 | $2.96 | 34.19 |
2012-12-31 | 88.72 | $2.01 | 44.06 |
2012-09-30 | 98.99 | $1.69 | 58.46 |
2012-06-30 | 100.42 | $1.75 | 57.42 |
2012-03-31 | 87.90 | $2.20 | 39.99 |
2011-12-31 | 82.72 | $1.75 | 47.30 |
2011-09-30 | 82.49 | $1.53 | 54.03 |
2011-06-30 | 74.58 | $0.99 | 75.54 |
2011-03-31 | 67.44 | $0.93 | 72.46 |
2010-12-31 | 53.66 | $0.99 | 54.34 |
2010-09-30 | 54.35 | $-1.59 | 0.00 |
2010-06-30 | 49.94 | $-0.31 | 0.00 |
2010-03-31 | 49.59 | $2.01 | 24.70 |
2015-06-30 | 158.77 | $-0.75 | 0.00 |
2009-12-31 | 33.59 | $1.43 | 23.52 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $4.263B | $4.656B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $196.909B | 25.56 |
Stryker (SYK) | United States | $136.478B | 33.84 |
Medtronic (MDT) | Ireland | $115.414B | 16.34 |
EssilorLuxottica (ESLOY) | France | $103.810B | 0.00 |
Boston Scientific (BSX) | United States | $100.864B | 33.47 |
Lonza Group Ag (LZAGY) | Switzerland | $44.257B | 0.00 |
Haleon (HLN) | United Kingdom | $39.385B | 30.46 |
ResMed (RMD) | United States | $28.878B | 28.87 |
Terumo (TRUMY) | Japan | $27.930B | 39.32 |
Zimmer Biomet Holdings (ZBH) | United States | $27.196B | 17.54 |
Baxter (BAX) | United States | $21.679B | 15.81 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $11.830B | 62.20 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.515B | 0.00 |
Demant (WILYY) | Denmark | $11.278B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.969B | 29.70 |
BellRing Brands (BRBR) | United States | $7.702B | 41.41 |
Haemonetics (HAE) | United States | $4.271B | 21.84 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Lantheus Holdings (LNTH) | United States | $4.145B | 10.70 |
Envista Holdings (NVST) | United States | $3.697B | 14.09 |
Prestige Consumer Healthcare (PBH) | United States | $3.606B | 17.05 |
Neogen (NEOG) | United States | $3.347B | 32.21 |
QuidelOrtho (QDEL) | United States | $3.226B | 11.71 |
Green Thumb Industries (GTBIF) | United States | $3.155B | 100.00 |
ICU Medical (ICUI) | United States | $2.484B | 18.71 |
TG Therapeutics (TGTX) | United States | $2.404B | 778.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.157B | 0.00 |
Verano Holdings (VRNOF) | United States | $2.151B | 0.00 |
Owens & Minor (OMI) | United States | $2.141B | 20.55 |
InMode (INMD) | Israel | $1.780B | 9.22 |
National Vision Holdings (EYE) | United States | $1.720B | 53.56 |
Agios Pharmaceuticals (AGIO) | United States | $1.636B | 0.00 |
AdaptHealth (AHCO) | United States | $1.510B | 11.36 |
LeMaitre Vascular (LMAT) | United States | $1.499B | 49.78 |
AtriCure (ATRC) | United States | $1.458B | 0.00 |
Warby Parker (WRBY) | United States | $1.303B | 0.00 |
MacroGenics (MGNX) | United States | $0.934B | 0.00 |
Quanterix (QTRX) | United States | $0.873B | 0.00 |
Canopy Growth (CGC) | Canada | $0.870B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.836B | 0.00 |
Evolus (EOLS) | United States | $0.811B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.716B | 15.47 |
TerrAscend (TSNDF) | Canada | $0.571B | 0.00 |
Valneva SE (VALN) | France | $0.553B | 0.00 |
Jin Medical (ZJYL) | China | $0.543B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.46 |
PetIQ (PETQ) | United States | $0.513B | 19.17 |
OraSure Technologies (OSUR) | United States | $0.470B | 7.77 |
ZimVie (ZIMV) | United States | $0.442B | 27.18 |
Biote (BTMD) | United States | $0.438B | 4.16 |
Surmodics (SRDX) | United States | $0.410B | 44.31 |
Zynex (ZYXI) | United States | $0.405B | 46.59 |
Viemed Healthcare (VMD) | United States | $0.364B | 36.08 |
Cerus (CERS) | United States | $0.325B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.322B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.252B | 15.36 |
TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.216B | 0.00 |
Omeros (OMER) | United States | $0.215B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.213B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.183B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.146B | 0.00 |
Fonar (FONR) | United States | $0.138B | 11.84 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.114B | 0.00 |
FitLife Brands (FTLF) | United States | $0.106B | 20.70 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Safety Shot (SHOT) | United States | $0.094B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.080B | 43.99 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Bright Green (BGXX) | United States | $0.047B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.85 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |